Advicenne Asset Resilience Ratio

Latest as of June 2025: 7.65%

Advicenne asset resilience ratio. Advicenne (ALDVI) has an Asset Resilience Ratio of 7.65% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ALDVI defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€515.00K

≈ $602.09K USD Cash + Short-term Investments

Total Assets

€6.73 Million

≈ $7.87 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Advicenne (2014–2024)

Asset resilience ratio of Advicenne from 2014 to 2024. This chart shows how Advicenne's Asset Resilience Ratio has changed over time. Read Advicenne (ALDVI) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Advicenne's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ALDVI total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€515.00K	7.65%
Short-term Investments	€0.00	0%
Total Liquid Assets	€515.00K	7.65%

Asset Resilience Insights

Limited Liquidity: Advicenne maintains only 7.65% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Advicenne Industry Peers by Asset Resilience Ratio

Compare Advicenne's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Advicenne Asset Resilience Ratio by Year (2014–2024)

Advicenne asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Advicenne.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	34.17%	€3.25 Million ≈ $3.80 Million	€9.51 Million ≈ $11.11 Million	-0.09pp
2023-12-31	34.26%	€4.25 Million ≈ $4.97 Million	€12.41 Million ≈ $14.51 Million	-24.12pp
2022-12-31	58.38%	€8.32 Million ≈ $9.73 Million	€14.26 Million ≈ $16.67 Million	-8.81pp
2021-12-31	67.18%	€12.69 Million ≈ $14.83 Million	€18.88 Million ≈ $22.07 Million	-2.68pp
2020-12-31	69.87%	€16.77 Million ≈ $19.61 Million	€24.00 Million ≈ $28.06 Million	-12.39pp
2019-12-31	82.26%	€18.85 Million ≈ $22.04 Million	€22.92 Million ≈ $26.80 Million	+1.96pp
2018-12-31	80.30%	€26.64 Million ≈ $31.14 Million	€33.17 Million ≈ $38.78 Million	-14.18pp
2017-12-31	94.47%	€36.48 Million ≈ $42.65 Million	€38.62 Million ≈ $45.15 Million	+45.86pp
2016-12-31	48.62%	€1.58 Million ≈ $1.85 Million	€3.26 Million ≈ $3.81 Million	-3.13pp
2015-12-31	51.75%	€1.54 Million ≈ $1.80 Million	€2.98 Million ≈ $3.48 Million	+7.10pp
2014-12-31	44.65%	€1.44 Million ≈ $1.68 Million	€3.22 Million ≈ $3.77 Million	--

pp = percentage points

About Advicenne

PA:ALDVI France Biotechnology

Market Cap

$11.19 Million

€9.57 Million EUR

Market Cap Rank

#26628 Global

#448 in France

Share Price

€0.66

Change (1 day)

+1.86%

52-Week Range

€0.62 - €2.21

All Time High

€15.27